Differences in the Tumor Microenvironment between African-American and European-American Breast Cancer Patients

Por Martin, Damali N., Boersma, Brenda J., Yi, Ming, Reimers, Mark, Howe, Tiffany M., Yfantis, Harry G., Tsai, Yien Che, Williams, Erica H., Lee, Dong H., Stephens, Robert M., Weissman, Allan M., Ambs, Stefan
Publicado em 2009

ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming

Por Mishra, Prachi, Tang, Wei, Putluri, Vasanta, Dorsey, Tiffany H., Jin, Feng, Wang, Fang, Zhu, Donewei, Amable, Lauren, Deng, Tao, Zhang, Shaofei, Killian, J. Keith, Wang, Yonghong, Minas, Tsion Z., Yfantis, Harry G., Lee, Dong H., Sreekumar, Arun, Bustin, Michael, Liu, Wei, Putluri, Nagireddy, Ambs, Stefan
Publicado no J Clin Invest (2017)

MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis

Por Terunuma, Atsushi, Putluri, Nagireddy, Mishra, Prachi, Mathé, Ewy A., Dorsey, Tiffany H., Yi, Ming, Wallace, Tiffany A., Issaq, Haleem J., Zhou, Ming, Killian, J. Keith, Stevenson, Holly S., Karoly, Edward D., Chan, King, Samanta, Susmita, Prieto, DaRue, Hsu, Tiffany Y.T., Kurley, Sarah J., Putluri, Vasanta, Sonavane, Rajni, Edelman, Daniel C., Wulff, Jacob, Starks, Adrienne M., Yang, Yinmeng, Kittles, Rick A., Yfantis, Harry G., Lee, Dong H., Ioffe, Olga B., Schiff, Rachel, Stephens, Robert M., Meltzer, Paul S., Veenstra, Timothy D., Westbrook, Thomas F., Sreekumar, Arun, Ambs, Stefan
Publicado em 2013